Accelerate Diagnostics Current Ratio 2010-2024 | AXDX
Accelerate Diagnostics current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Accelerate Diagnostics Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $0.03B | $0.02B | 1.50 |
| 2024-06-30 | $0.02B | $0.01B | 1.28 |
| 2024-03-31 | $0.02B | $0.02B | 1.50 |
| 2023-12-31 | $0.02B | $0.01B | 2.03 |
| 2023-09-30 | $0.03B | $0.04B | 0.86 |
| 2023-06-30 | $0.04B | $0.05B | 0.79 |
| 2023-03-31 | $0.04B | $0.07B | 0.63 |
| 2022-12-31 | $0.06B | $0.07B | 0.84 |
| 2022-09-30 | $0.07B | $0.07B | 1.00 |
| 2022-06-30 | $0.05B | $0.07B | 0.72 |
| 2022-03-31 | $0.06B | $0.11B | 0.54 |
| 2021-12-31 | $0.07B | $0.01B | 10.56 |
| 2021-09-30 | $0.07B | $0.01B | 9.52 |
| 2021-06-30 | $0.08B | $0.01B | 8.98 |
| 2021-03-31 | $0.08B | $0.01B | 11.11 |
| 2020-12-31 | $0.08B | $0.01B | 11.77 |
| 2020-09-30 | $0.09B | $0.01B | 13.02 |
| 2020-06-30 | $0.10B | $0.01B | 10.13 |
| 2020-03-31 | $0.11B | $0.01B | 16.03 |
| 2019-12-31 | $0.12B | $0.01B | 14.93 |
| 2019-09-30 | $0.13B | $0.01B | 21.93 |
| 2019-06-30 | $0.15B | $0.01B | 19.99 |
| 2019-03-31 | $0.16B | $0.01B | 25.36 |
| 2018-12-31 | $0.18B | $0.01B | 22.88 |
| 2018-09-30 | $0.19B | $0.01B | 35.26 |
| 2018-06-30 | $0.21B | $0.01B | 27.11 |
| 2018-03-31 | $0.21B | $0.01B | 27.79 |
| 2017-12-31 | $0.12B | $0.01B | 17.75 |
| 2017-09-30 | $0.13B | $0.01B | 21.23 |
| 2017-06-30 | $0.14B | $0.01B | 23.02 |
| 2017-03-31 | $0.07B | $0.01B | 13.40 |
| 2016-12-31 | $0.08B | $0.00B | 19.44 |
| 2016-09-30 | $0.09B | $0.00B | 20.61 |
| 2016-06-30 | $0.11B | $0.00B | 23.56 |
| 2016-03-31 | $0.12B | $0.01B | 24.12 |
| 2015-12-31 | $0.13B | $0.01B | 25.28 |
| 2015-09-30 | $0.04B | $0.00B | 11.47 |
| 2015-06-30 | $0.05B | $0.00B | 16.49 |
| 2015-03-31 | $0.06B | $0.00B | 17.04 |
| 2014-12-31 | $0.07B | $0.00B | 24.11 |
| 2014-09-30 | $0.07B | $0.00B | 35.24 |
| 2014-06-30 | $0.08B | $0.00B | 35.41 |
| 2014-03-31 | $0.04B | $0.00B | 23.18 |
| 2013-12-31 | $0.04B | $0.00B | 37.07 |
| 2013-09-30 | $0.05B | $0.00B | 108.36 |
| 2013-06-30 | $0.03B | $0.00B | 15.56 |
| 2013-03-31 | $0.03B | $0.00B | 26.53 |
| 2012-12-31 | $0.01B | $0.00B | 10.30 |
| 2012-10-31 | $0.01B | $0.00B | 9.71 |
| 2012-09-30 | $0.00B | 0.00 | |
| 2012-07-31 | $0.02B | $0.00B | 10.81 |
| 2012-06-30 | $0.00B | 0.00 | |
| 2012-04-30 | $0.00B | $0.00B | 4.64 |
| 2012-03-31 | $0.00B | 0.00 | |
| 2012-01-31 | $0.00B | $0.00B | 5.11 |
| 2011-10-31 | $0.00B | $0.00B | 7.00 |
| 2011-07-31 | $0.00B | $0.00B | 20.53 |
| 2011-04-30 | $0.00B | $0.00B | 6.51 |
| 2011-01-31 | $0.00B | $0.00B | 7.67 |
| 2010-10-31 | $0.00B | $0.00B | 8.21 |
| 2010-07-31 | $0.00B | $0.00B | 9.92 |
| 2010-04-30 | $0.00B | $0.00B | 1.95 |
| 2010-01-31 | $0.00B | $0.00B | 1.57 |
| 2009-10-31 | $0.00B | $0.00B | 3.50 |
| 2009-07-31 | $0.00B | $0.00B | 5.97 |
| 2009-04-30 | $0.00B | $0.00B | 4.00 |
| 2009-01-31 | $0.00B | $0.00B | 5.33 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.018B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $187.725B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $176.405B | 80.93 |
| Alcon (ALC) | Switzerland | $46.824B | 31.12 |
| Edwards Lifesciences (EW) | United States | $42.608B | 27.66 |
| IDEXX Laboratories (IDXX) | United States | $34.032B | 39.36 |
| IQVIA Holdings (IQV) | United States | $31.084B | 17.20 |
| DexCom (DXCM) | United States | $26.777B | 41.39 |
| Mettler-Toledo (MTD) | United States | $24.611B | 28.69 |
| STERIS (STE) | Ireland | $22.269B | 25.47 |
| Waters (WAT) | United States | $21.897B | 31.05 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.380B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.612B | 14.91 |
| Hologic (HOLX) | United States | $13.861B | 14.96 |
| Sysmex ADR (SSMXY) | Japan | $11.941B | 37.44 |
| Penumbra (PEN) | United States | $10.300B | 93.17 |
| Globus Medical (GMED) | United States | $10.068B | 23.31 |
| Masimo (MASI) | United States | $9.002B | 37.78 |
| Teleflex (TFX) | United States | $6.407B | 9.86 |
| Glaukos (GKOS) | United States | $5.567B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.967B | 22.27 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| Veracyte (VCYT) | United States | $2.311B | 41.76 |
| TransMedics (TMDX) | United States | $2.265B | 66.61 |
| Nihon Kohden (NHNKY) | Japan | $2.205B | 12.06 |
| LivaNova (LIVN) | United Kingdom | $2.135B | 12.96 |
| Elekta AB (EKTAY) | Sweden | $1.995B | 17.93 |
| Integra LifeSciences Holdings (IART) | United States | $1.698B | 8.59 |
| Alphatec Holdings (ATEC) | United States | $1.462B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.274B | 0.00 |
| OPKO Health (OPK) | United States | $1.115B | 0.00 |
| Paragon 28 (FNA) | United States | $1.096B | 0.00 |
| Artivion (AORT) | United States | $1.034B | 98.32 |
| RxSight (RXST) | United States | $1.022B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| AxoGen (AXGN) | United States | $0.820B | 0.00 |
| IRadimed (IRMD) | United States | $0.667B | 34.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 10.61 |
| Mesa Laboratories (MLAB) | United States | $0.645B | 14.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.636B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.598B | 0.00 |
| SiBone (SIBN) | United States | $0.596B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.531B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.525B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.425B | 0.00 |
| NeuroPace (NPCE) | United States | $0.400B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.380B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.351B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.37 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| CVRx (CVRX) | United States | $0.318B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.313B | 16.73 |
| Nevro (NVRO) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.177B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| 908 Devices (MASS) | United States | $0.158B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.123B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.117B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.114B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 11.82 |
| EDAP TMS S.A (EDAP) | France | $0.073B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.027B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |